DS
APYX icon

David Shaw’s Apyx Medical APYX Stock Holding History

David Shaw’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,586
Closed -$144K – 5165
2022
Q2 		$144K Buy
+24,586
New +$126K ﹤0.01% 4655

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

David Shaw's APYX Position: Q3 2022 in Review

David Shaw sold out of Apyx Medical (APYX) in Q3 2022, closing a stake of 24,586 shares — an estimated $144K sold.

David Shaw first reported a position in APYX in Q2 2022 and held it in 1 quarter. The position peaked at $144K in Q2 2022. 54 funds tracked by Wall St. Rank hold APYX as of Q3 2022.

  • David Shaw reported no remaining Apyx Medical position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 24,586 Apyx Medical shares in Q3 2022, an estimated $144K.
  • David Shaw first reported a position in Apyx Medical in Q2 2022 and held it in 1 quarter.
  • David Shaw's Apyx Medical position peaked at $144K in Q2 2022.
  • 54 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.